Inhibrx Announces Participation in Upcoming Scientific Conference
Inhibrx(US:INBX) Prnewswire·2026-03-02 21:00Inhibrx Announces Participation in Upcoming Scientific Conference [Accessibility Statement] Skip NavigationSAN DIEGO, March 2, 2026 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, today announced it will be presenting at the following upcoming scientific conference:ESMO Sarcoma and Rare Cancers CongressMarch 12th- 14th, 2026; Lugano SwitzerlandTitle: Phase 1 Study of th ...